Havens Advisors LLC’s Alexion Pharmaceuticals Inc Position
Does Havens Advisors LLC own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 54.0K shares worth $10M in Q2 2021; the fund’s latest 13F (Q4 2022) no longer reports it.
Position Value
$10M
Q2 2021
Shares
54.0K
% of Portfolio
+7.88%
Quarters Held
3
position exited
Position History ALXN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Havens Advisors LLC’s full portfolio or all institutional holders of ALXN.